Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Nitric Oxide Activation of p38 Mitogen-activated Protein Kinase in 293T Fibroblasts Requires cGMP-dependent Protein Kinase

2000; Elsevier BV; Volume: 275; Issue: 4 Linguagem: Inglês

10.1074/jbc.275.4.2811

ISSN

1083-351X

Autores

Darren D. Browning, Marisa P. McShane, Caroline Marty, Richard D. Ye,

Tópico(s)

Protein Kinase Regulation and GTPase Signaling

Resumo

An increase in cellular levels of cyclic nucleotides activates serine/threonine-dependent kinases that lead to diverse physiological effects. Recently we reported the activation of the p38 mitogen-activated protein kinase (MAPK) pathway in neutrophils by a cGMP-dependent mechanism. In this study we demonstrated that exogenously supplied nitric oxide leads to activation of p38 MAPK in 293T fibroblasts. Phosphorylation of p38 corresponded with an increase in ATF-2-dependent gene expression. The effect of nitric oxide was mimicked by addition of 8-bromo-cGMP, indicating that activation of soluble guanylyl cyclase was involved. The importance of cGMP-dependent protein kinase in the activation of p38 MAPK by nitric oxide in 293T cells was assessed in a transfection based assay. Overexpression of cGMP-dependent protein kinase-1α caused phosphorylation of p38 in these cells and potentiated the effectiveness of cGMP. Overexpression of a catalytically inactive mutant form of this enzyme (T516A) blocked the ability of both nitric oxide and 8-bromo-cGMP to activate p38 as measured by both p38 phosphorylation and ATF-2 driven gene expression. Together, these data demonstrate that nitric oxide stimulates a novel pathway leading to activation of p38 MAPK that requires activation of cGMP-dependent protein kinase. An increase in cellular levels of cyclic nucleotides activates serine/threonine-dependent kinases that lead to diverse physiological effects. Recently we reported the activation of the p38 mitogen-activated protein kinase (MAPK) pathway in neutrophils by a cGMP-dependent mechanism. In this study we demonstrated that exogenously supplied nitric oxide leads to activation of p38 MAPK in 293T fibroblasts. Phosphorylation of p38 corresponded with an increase in ATF-2-dependent gene expression. The effect of nitric oxide was mimicked by addition of 8-bromo-cGMP, indicating that activation of soluble guanylyl cyclase was involved. The importance of cGMP-dependent protein kinase in the activation of p38 MAPK by nitric oxide in 293T cells was assessed in a transfection based assay. Overexpression of cGMP-dependent protein kinase-1α caused phosphorylation of p38 in these cells and potentiated the effectiveness of cGMP. Overexpression of a catalytically inactive mutant form of this enzyme (T516A) blocked the ability of both nitric oxide and 8-bromo-cGMP to activate p38 as measured by both p38 phosphorylation and ATF-2 driven gene expression. Together, these data demonstrate that nitric oxide stimulates a novel pathway leading to activation of p38 MAPK that requires activation of cGMP-dependent protein kinase. protein kinase mitogen-activated protein kinase extracellular signal-regulated kinase c-Jun NH2-terminal kinase MAPK kinase 8-bromo cyclic GMP vasodilator-stimulated phosphoprotein sodium nitroprusside polymerase chain reaction apoptosis signal-regulated kinase tumor necrosis factor Nitric oxide (NO) is an important signaling molecule that can affect many tissues to regulate diverse physiological processes, including smooth muscle relaxation, inflammation, platelet activation, apoptosis, and neuronal function (1.Moilanen E. Vapaatalo H. Ann. Med. 1995; 27: 359-367Crossref PubMed Scopus (218) Google Scholar, 2.Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (454) Google Scholar, 3.Wang X. Robinson P.J. J. Neurochem. 1997; 68: 443-456Crossref PubMed Scopus (271) Google Scholar, 4.Zhuo M. Hu Y. Schultz C. Kandel E.R. Hawkins R.D. Nature. 1994; 368: 635-639Crossref PubMed Scopus (357) Google Scholar, 5.Archer S.L. Huang J.M. Hampl V. Nelson D.P. Shultz P.J. Weir E.K. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 7583-7587Crossref PubMed Scopus (736) Google Scholar). Several mechanisms have been described for NO function, including nitrosylation of key thiol groups of susceptible proteins, formation of reactive peroxynitrite, stimulation of ADP-ribosylation, and activation of soluble guanylyl cyclase (6.McDonald L.J. Moss J. Mol. Cell. Biochem. 1994; 138: 201-206Crossref PubMed Scopus (25) Google Scholar, 7.Stamler J.S. Cell. 1994; 78: 931-936Abstract Full Text PDF PubMed Scopus (1630) Google Scholar, 8.Brune B. Dimmeler S. Molina y Vedia L. Lapetina E.G. Life Sci. 1994; 54: 61-70Crossref PubMed Scopus (128) Google Scholar, 9.Brune B. Mohr S. Messmer U.K. Rev. Physiol. Biochem. Pharmacol. 1996; 127: 1-30Crossref PubMed Google Scholar, 10.Willmott N. Sethi J.K. Walseth T.F. Lee H.C. White A.M. Galione A. J. Biol. Chem. 1996; 271: 3699-3705Abstract Full Text Full Text PDF PubMed Scopus (209) Google Scholar, 11.Kim Y.M. Talanian R.V. Billiar T.R. J. Biol. Chem. 1997; 272: 31138-31148Abstract Full Text Full Text PDF PubMed Scopus (796) Google Scholar, 12.Hobbs A.J. Trends Pharmacol. Sci. 1997; 18: 484-491Abstract Full Text PDF PubMed Scopus (244) Google Scholar). Guanylyl cyclase converts available GTP into cGMP that behaves as a second messenger by activating cyclic nucleotide dependent protein kinases (12.Hobbs A.J. Trends Pharmacol. Sci. 1997; 18: 484-491Abstract Full Text PDF PubMed Scopus (244) Google Scholar). Increases in either cAMP or cGMP are capable of activating both protein kinase A (PKA)1 and protein kinase G (PKG), but the former is responsive to lower levels of cAMP and the latter is more sensitive to cGMP. In the past, the lower expression relative to PKA has made it difficult to identify processes regulated specifically by PKG, although specific inhibitors such as KT5823 have often been used to suggest the importance of this enzyme. It has been reported that some effects of NO, including activation of gene expression and apoptosis, may be mediated by mitogen activated kinases (MAPK) (12.Hobbs A.J. Trends Pharmacol. Sci. 1997; 18: 484-491Abstract Full Text PDF PubMed Scopus (244) Google Scholar, 13.Callsen D. Pfeilschifter J. Brune B. J. Immunol. 1998; 161: 4852-4858PubMed Google Scholar, 14.Callsen D. Brune B. Biochemistry. 1999; 38: 2279-2286Crossref PubMed Scopus (99) Google Scholar, 15.Browning D.D. Windes N.D. Ye R.D. J. Biol. Chem. 1999; 274: 537-542Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 16.Kanterewicz B.I. Knapp L.T. Klann E. J. Neurochem. 1998; 70: 1009-1016Crossref PubMed Scopus (90) Google Scholar, 17.Parenti A. Morbidelli L. Cui X.L. Douglas J.G. Hood J.D. Granger H.J. Ledda F. Ziche M. J. Biol. Chem. 1998; 273: 4220-4226Abstract Full Text Full Text PDF PubMed Scopus (396) Google Scholar, 18.Schieke S.M. Briviba K. Klotz L.O. Sies H. FEBS Lett. 1999; 448: 301-303Crossref PubMed Scopus (115) Google Scholar, 19.Sciorati C. Nistico G. Meldolesi J. Clementi E. Br. J. Pharmacol. 1997; 122: 687-697Crossref PubMed Scopus (45) Google Scholar, 20.Lander H.M. Jacovina A.T. Davis R.J. Tauras J.M. J. Biol. Chem. 1996; 271: 19705-19709Abstract Full Text Full Text PDF PubMed Scopus (278) Google Scholar). The MAP-kinases including extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK) and p38 represent a family of proteins that are activated by phosphorylation by upstream MAPK kinases (MEKs), which are activated in response to growth factors, cytokines, or various forms of cellular stress (21.Paul A. Wilson S. Belham C.M. Robinson C.J. Scott P.H. Gould G.W. Plevin R. Cell. Signalling. 1997; 9: 403-410Crossref PubMed Scopus (285) Google Scholar, 22.Robinson M.J. Cobb M.H. Curr. Opin. Cell Biol. 1997; 9: 180-186Crossref PubMed Scopus (2278) Google Scholar, 23.Seger R. Ahn N.G. Posada J. Munar E.S. Jensen A.M. Cooper J.A. Cobb M.H. Krebs E.G. J. Biol. Chem. 1992; 267: 14373-14381Abstract Full Text PDF PubMed Google Scholar). MAPKs regulate fundamental cellular processes such as growth and differentiation by activating transcription factors (24.Su B. Karin M. Curr. Opin. Immunol. 1996; 8: 402-411Crossref PubMed Scopus (714) Google Scholar,25.Treisman R. Curr. Opin. Cell Biol. 1996; 8: 205-215Crossref PubMed Scopus (1160) Google Scholar). Several studies have addressed the mechanism of NO-mediated activation of the ERK pathway. In Jurkat and murine neuronal cells activation of ERK is cGMP-independent, and there is evidence for nitrosylation of p21 ras, which can then activate the c-Raf/MEK1,2 pathway (20.Lander H.M. Jacovina A.T. Davis R.J. Tauras J.M. J. Biol. Chem. 1996; 271: 19705-19709Abstract Full Text Full Text PDF PubMed Scopus (278) Google Scholar, 26.Tamura N. Itoh H. Ogawa Y. Nakagawa O. Harada M. Chun T.H. Suga S. Yoshimasa T. Nakao K. Hypertension. 1996; 27: 552-557Crossref PubMed Google Scholar, 27.Yun H.Y. Gonzalez-Zulueta M. Dawson V.L. Dawson T.M. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 5773-5778Crossref PubMed Scopus (176) Google Scholar). More recently it has been shown that activation of ERK in endothelial cells by NO required cGMP formation (28.Hood J. Granger H.J. J. Biol. Chem. 1998; 273: 23504-23508Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). Furthermore, using KT5823, these authors demonstrated a role for cGMP-dependent protein kinase (PKG) in a process involving phosphorylation and activation of c-Raf. Of interest, the PKG mediated phosphorylation of c-Raf has also been shown to prevent its coupling to Ras and therefore inhibits growth factor-induced ERK activation in baby hamster kidney cells (29.Suhasini M. Li H. Lohmann S.M. Boss G.R. Pilz R.B. Mol. Cell. Biol. 1998; 18: 6983-6994Crossref PubMed Scopus (100) Google Scholar). Thus it is likely that NO can activate the ERK pathway using a combination of both events. Despite several reports of the phenomenon in different cell types, the events underlying the activation of JNK or p38 MAP-kinase by NO stimulation remain unclear (14.Callsen D. Brune B. Biochemistry. 1999; 38: 2279-2286Crossref PubMed Scopus (99) Google Scholar, 15.Browning D.D. Windes N.D. Ye R.D. J. Biol. Chem. 1999; 274: 537-542Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 18.Schieke S.M. Briviba K. Klotz L.O. Sies H. FEBS Lett. 1999; 448: 301-303Crossref PubMed Scopus (115) Google Scholar, 20.Lander H.M. Jacovina A.T. Davis R.J. Tauras J.M. J. Biol. Chem. 1996; 271: 19705-19709Abstract Full Text Full Text PDF PubMed Scopus (278) Google Scholar, 30.Lo Y.Y.C. Wong J.M.S. Cruz T.F. J. Biol. Chem. 1996; 271: 15703-15707Abstract Full Text Full Text PDF PubMed Scopus (452) Google Scholar). Using peroxynitrite to stimulate rat liver epithelial cells, it has been suggested that protein nitrosylation might be important to activation of p38 MAPK. Recently we reported that NO could specifically activate MEK3 and p38 MAPK in human neutrophils (15.Browning D.D. Windes N.D. Ye R.D. J. Biol. Chem. 1999; 274: 537-542Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). The importance of PKG in this system has been suggested by the ability of increased cGMP levels to mimic the effect of NO and that KT5823 was able to block p38 MAPK activation by lipopolysaccharide. This study investigated the mechanism of NO induced activation of p38 MAPK. We report that exogenous NO leads to phosphorylation of p38 MAPK in 293T fibroblasts and that this results in ATF-2-dependent gene expression. In addition, it was found that cGMP can mimic this response, and using a catalytic mutant of PKG we demonstrate that this enzyme is essential for both of these functions. BPDEtide, H-89 and, 8-Br-cGMP were obtained from BIOMOL Research Laboratories, Inc. (Plymouth Meeting, PA). Protease inhibitor mixture, sodium nitroprusside (SNP-1), and Nonidet P-40 were from Calbiochem. p81 phosphocellulose was obtained from Upstate Biotechnology Inc. (Lake Placid, NY), and [γ-32P]ATP was from Amersham Pharmacia Biotech, Inc. All other chemicals were obtained from Sigma. The PKG constructs were cloned as detailed below. Antibodies raised against PKG and PKA-R were purchased from Upstate Biotechnology Inc. (Lake Placid, NY). The murine FLAG epitope-tagged VASP protein was a gift from Dr. Michael Uhler (University of Michigan). Wild-type ASK-1 was a gift from Dr. Tatyana Voyno-Yasenetskaya (University of Illinois, Chicago). The dominant negative regulatory subunit for murine PKA (δR1α) was a gift from Dr. Stanley McKnight (University of Washington, Seattle, WA). The cGMP accumulation in response to treatment of 293T cells with nitric oxide was determined using an competitive enzyme-linked immunosorbent assay-based kit (BIOMOL Research Laboratories, Inc., Plymouth Meeting, PA). For these assays the cells from 10-cm dishes (approximately 2 × 106) were treated with SNP-1, and at various times the cells were washed in ice-cold phosphate-buffered saline and divided into two fractions for duplicate measurements. The cell extracts were prepared with 0.1 m HCl, and the cGMP was acylated and quantitated according to the manufacturer's instructions. The human embryonic kidney fibroblast cell line 293T was maintained in RPMI 1640 medium (Life Technologies, Inc.) containing 10% fetal bovine serum (Omega Scientific). The cells were grown on 10-cm tissue culture plates and split by repeated pipetting to remove them from the dish. Cells were transfected to express exogenous proteins and reporter constructs using the calcium phosphate precipitation method. In all cases the DNA concentration was kept to 10 μg in 1 ml of precipitate using empty pRK7 vector. DNA precipitate (1 ml for a 10-cm dish or 0.15 ml for a well of a six-well plate, respectively) was added to the cells and incubated for 4 h. After changing the medium cells were incubated for an additional 20–24 h before experimentation. The expression of δR1α driven by the MT-1 promotor was induced by changing the incubation of the transfected cells for an additional 16 h in RPMI 1640 containing 2.5% fetal bovine serum and 100 μmZnCl2. In some studies, including the luciferase reporter experiments, cells were serum starved for 12–16 h before use. Two fragments of PKG1α were cloned by PCR using the PCR-Script vector according to manufacturer instructions (Stratagene, La Jolla, CA). The template cDNA was prepared by reverse transcriptase using human lung RNA (CLONTECH, Palo Alto, CA). The two fragments were joined using a unique PstI restriction site, and the full-length construct was subcloned into BamHI andEcoRI sites of the pCDNA3.1 expression vector. The PKG1α mutant T516A was made with the 3′ cDNA fragment containing the catalytic region by PCR, and the mutant fragment was joined via thePstI site into PCR-Script vector as mentioned above. Verification of both wild-type and mutant forms of PKG1α was assessed by sequencing, which indicated no mutations from published sequence except for the T516A replacement. Expression of the PKG1α constructs in pCDNA3.1 was assessed by transfecting the 293T cells followed by Western blotting with a commercially available COOH-terminal specific polyclonal anti-bovine PKG antibody (Upstate Biotechnology Inc., Lake Placid, NY). The kinase activity of the expressed enzymes was measured in cell homogenates using BPDEtide as substrate as detailed previously (31.Collins S.P. Uhler M.D. J. Biol. Chem. 1999; 274: 8391-8404Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar) except that 0.5 μm of the PKA inhibitor H89 was incorporated in the reaction mixture instead of inhibitory peptide. A truncated version of type 1 PKG corresponding to the PKA-C1α catalytic subunit gene was generated by PCR using the full-length coding sequence described above and the fragment subcloned into the pCDNA3.1 expression vector. Assessment of the phosphorylation state of p38 MAPK in 293T cells was accomplished by Western blotting using a polyclonal anti-phospho-p38 MAPK antibody (New England Biolabs, Beverly, MA) and visualized with enhanced chemiluminescence (Pierce). Briefly, the medium was removed from cells grown on 10-cm dishes and replaced by serum-free RPMI 1640. After treatment in this medium the plates were immediately placed on ice and the RPMI replaced by 10 ml of ice-cold phosphate-buffered saline. The cells were removed from the plates by repeated pipetting and harvested by centrifugation at 1000 × g at 4 °C. For some experiments cell extracts were made by resuspending the cells in denaturing sample buffer and analyzed by Western blotting directly. In these experiments the protein loading in each lane (approximately 20 μg) was assessed by reprobing the blots with antibodies against unphosphorylated p38. In other experiments involving transfection of FLAG epitope-tagged p38 (a generous gift from Dr. J. Han, Scripps Research Institute), the cell pellet was resuspended in lysis buffer (50 mm Tris-HCl, pH 8.0, 1 mm EDTA, 1% Nonidet P-40, 150 mm NaCl, 1 mm sodium vanadate, 5 mm sodium fluoride, and 1 × protease inhibitor mixture) and agitated at 4 °C for 20 min. Following clarification by centrifugation, the exogenously expressed p38 was immunoprecipitated from the extracts using anti-FLAG M2 coupled to agarose (Eastman Kodak Co.). The p38 in the washed precipitates was then eluted from the beads by incubating 10 min on ice in 400 μg/ml FLAG peptide, and after removing the beads, fractions of the supernatant were analyzed by Western blotting with the anti-phospho-p38 antibody. Reprobing with monoclonal anti-FLAG M2 did standardization of the p38 loading on the blots. In some instances quantitation of p38 MAPK phosphorylation was accomplished by scanning autoradiograms followed by densitometric analysis with ImageQuant software (V3.3, Molecular Dynamics). The intensity of the phosphorylated p38 was standardized with the intensity of the total p38 MAPK and expressed as a ratio of the basal level. Transcriptional activity stimulated by p38 activation was measured using the Path-Detect ATF-2-dependent luciferase reporter assay (Stratagene, La Jolla, CA). In these experiments the 293T cells were cultured in six-well dishes and transfected with 150 μl of DNA precipitate containing 75 ng of luciferase reporter and 0.4 ng of ATF-2 fusion vector as detailed above. After approximately 36 h the transfected cells were stimulated for 6 additional hours. Luciferase activity in cell lysates was determined using luminol substrate according to the manufacturer's recommendations. The MAPKs are activated by phosphorylation of specific tyrosine and threonine residues by dual specificity MEKs. Thus the phosphorylation state of any MAPK is a good measure of the activation of the enzyme. The ability of the nitric oxide-releasing compound sodium nitroprusside (SNP-1) to activate p38 MAPK in 293T cells was assessed by Western blotting with a polyclonal antiserum specific for the phosphorylated version of p38 MAPK. There was some background phospho-p38 in unstimulated cells, but as early as 5 min after challenge with 100 μm SNP-1, this level increased and was maximal after 15 min (Fig.1 A). A major effector function of NO is guanylyl cyclase, which leads to an increase in cellular cGMP levels. Treatment of 293T cells with 100 μm SNP-1 resulted in a rapid increase in cellular cGMP and was maximal 15–20 min following stimulation (Fig. 1 B). The kinetics of cGMP formation paralleled that of p38 MAPK phosphorylation in response to SNP-1 treatment. Because NO is capable of influencing cell physiology by several means, it was of interest to determine whether cGMP was able to cause p38 MAPK phosphorylation in these cells. To test this hypothesis the membrane-permeable cGMP analogue 8-bromo-cGMP was added to cells and found to induce a rapid increase in the amount of phospho-p38. In these experiments the activity was detectable within 30 s and peaked within 5 min following addition of the 8-Br-cGMP (Fig. 1 C). The stimulation of p38 MAPK phosphorylation by cGMP and SNP-1 were not additive, suggesting that they are part of the same pathway (data not shown). These observations are consistent with the notion that an increase in cellular cGMP levels resulting from activation of soluble guanylyl cyclase was central to NO mediated phosphorylation of p38 MAPK in the 293T cells. These data are very similar to those reported in neutrophils indicating that this phenomenon is not restricted to leukocytes. Indeed, we examined the ability of 8-Br-cGMP to stimulate phosphorylation of p38 MAPK in several myeloid lines (THP-1, HL-60, U937) and fibroblast lines (COS-7, HEK-293) and found that this nucleotide was effective although to varying degrees in all cells tested (data not shown). To address in more detail the mechanism underlying the cGMP-stimulated p38 activation, we transiently transfected 293T cells with FLAG epitope-tagged p38 MAPK followed by immunoprecipitation and Western blotting (Fig. 2 A). Of potential importance was the observation that the increase in phospho-p38 induced by SNP-1 or 8-Br-cGMP was much lower (approximately 2-fold basal levels) than that found in cells stimulated with tumor necrosis factor. The physiological significance of the relatively low levels of p38 phosphorylation by NO and cGMP was tested in terms of the ability of these agents to initiate ATF-2 dependent gene expression. ATF-2 is a well characterized transcription factor that is activated in response to phosphorylation by p38 MAPK. Transfection of ATF-2/luciferase reporter constructs into 293T cells resulted in some basal luciferase activity in the unstimulated cells. Cotransfection of the cells with ASK-1, a MEK kinase known to activate MEK3, resulted in increases in luciferase activity of up to 10-fold (data not shown). Stimulation of 293 cells transfected with the ATF-2/luciferase reporter constructs with 400 ng/ml TNFα for 6 h resulted in a 4-fold increase in the basal luciferase activity (Fig. 2 C). Furthermore, treatment of the cells with SB203580, a potent and specific inhibitor of p38 MAPK, was able to block the increase in luciferase activity in the stimulated cells confirming that the increases observed were due to activation of p38 MAPK (data not shown). Stimulation of the cells with either 100 μm SNP-1 or 250 μm 8-Br-cGMP for 6 h produced similar increases in ATF-2-dependent luciferase activity to that of TNFα (Fig.2 B) Although there are several cGMP-binding proteins present in cells, PKG is believed to function in a signaling capacity and has been demonstrated to be downstream of NO (12.Hobbs A.J. Trends Pharmacol. Sci. 1997; 18: 484-491Abstract Full Text PDF PubMed Scopus (244) Google Scholar). Because of the ability of cyclic nucleotides to cross-activate both PKA and PKG, it was important to determine whether the exogenously added 8-Br-cGMP was able to activate PKA. To test this, a cyclic nucleotide unresponsive regulatory subunit for PKA (δR1α), which behaves in a dominant negative fashion, was transfected into 293T cells. To measure the activation of PKA and PKG we took advantage of the fact that VASP is a substrate for both kinases and expressed a FLAG epitope-tagged version, which could be immunoprecipitated from the cells and its phosphorylation measured as a mobility shift on Western blots (31.Collins S.P. Uhler M.D. J. Biol. Chem. 1999; 274: 8391-8404Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar). It was found that 250 μm 8-Br-cAMP or cGMP could phosphorylate VASP, but the cAMP was twice as effective (Fig.3 A). The greater efficacy of cAMP likely reflects differences in expression levels of the two kinases as PKG isoforms are generally less abundant. Expression of δR1α effectively blocked the ability of the cAMP to phosphorylate VASP, reducing the amount of phospho-VASP to close to basal levels. Overexpression of δR1α did not significantly reduce the phosphorylation of VASP by cGMP. Taken together these data demonstrate the effectiveness of the δR1α to shut down the PKA system and suggest that at 250 μm 8-Br-cAMP or cGMP there is no cross-activation of PKA and PKG in these cells. The importance of PKG downstream of cGMP in that activation of p38 MAPK was further supported by the ability of this nucleotide to cause p38 MAPK phosphorylation in cells transfected to express δR1α with almost identical kinetics to cells with a functional PKA system (Fig. 3 B). The type 1 isoforms of PKG are more widely distributed than type 2 and are the enzymes found in immune cells (32.Lohmann S.M. Vaandrager A.B. Smolenski A. Walter U. De Jonge H.R. Trends Biochem. Sci. 1997; 22: 307-312Abstract Full Text PDF PubMed Scopus (350) Google Scholar). To test the importance of PKG in the activation of p38 MAPK by NO, PKG1α was cloned, and a catalytically inactive mutant construct of this enzyme was generated for use in the 293T cell transfection system. The T516A mutation has been previously characterized and shown to prevent the phosphorylation of a conserved threonine residue located in the catalytic region of the enzyme, a process thought to be essential for the catalytic function of this enzyme (33.Feil R. Kellermann J. Hofmann F. Biochemistry. 1995; 34: 13152-13158Crossref PubMed Scopus (29) Google Scholar). Low levels of PKG activity were measured in untransfected or mock-transfected 293T cells using a peptide substrate based assay (Fig. 4). Transfection of the cells with either wild-type or the T516A mutant construct resulted in overexpression of the protein which was detected as an intense band migrating at 80-kDa on Western blots probed with a polyclonal anti-PKG antibody (Fig. 4, inset). PKG activity in cell homogenates was not significantly altered by transfection of the T516A mutant confirming the absence of catalytic function. In homogenates transfected with the wild-type PKG1α, the activity was approximately 10-fold higher than in mock-transfected cells and the ratio of basal to cGMP stimulated activity was identical. The importance of PKG in cGMP-mediated stimulation of phospho-p38 was assessed by cotransfecting the wild-type and T516A mutant isoforms of PKG1α with the FLAG epitope-tagged p38 MAPK followed by immunoprecipitation and Western blotting. In these experiments overexpression of the catalytic mutant blocked the ability of 8-Br-cGMP to increase p38 phosphorylation (Fig.5). Furthermore, the increased levels of phospho-p38 that were found in 8-Br-cGMP-stimulated cells was further elevated in cells transfected to overexpress PKG1α. The ability of the wild-type PKG construct to enhance cGMP-stimulated p38 MAPK activation was variable and probably depends on the abundance of endogenous PKG, which was also appeared to vary with culture age (not shown). Other than the cyclic nucleotide specificity, a major difference between PKA and PKG is that distinct PKA genes encode the regulatory and catalytic subunits whereas they are present as separate domains in a single polypeptide in PKG. Expression of the catalytic region of type 1 PKG produces a constitutive activity that is insensitive to cGMP (31.Collins S.P. Uhler M.D. J. Biol. Chem. 1999; 274: 8391-8404Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar). When overexpressed, the truncated PKG was able to stimulate p38 MAPK phosphorylation in the absence of cGMP stimulation (Fig. 6). Of interest, the constitutive PKG produced lower levels of p38 MAPK phosphorylation than overexpressed ASK-1, which is known to directly activate MEK3 in the p38 pathway.Figure 5Involvement of PKG in cGMP-induced phosphorylation of p38 MAPK. The effect of transfecting 293T fibroblasts to express wild-type or mutant PKG1α (T516A) on cGMP stimulated p38 phosphorylation was determined. Cells were cotransfected with 1 μg of FLAG-p38, and either 0.1 or 1 μg of PKG construct and 24 h later were stimulated with 250 μm8-Br-cGMP for 5 min. The cell homogenates were subjected to immunoprecipitation with anti-FLAG M2 and the precipitates analyzed for phospho-p38 content by Western blotting (top panel). The level of phospho-p38 found in unstimulated cells is shown as "Basal." Equal loading of the lanes is shown by probing the immunoprecipitates with anti-FLAG M2 antibody (middle panel). The expression of PKG1α in the transfected cells was determined by measuring PKG protein in the cell homogenates by Western blotting with anti-PKG serum (lower panel) (A). The phosphorylation of p38 MAPK detected by Western blot analysis was quantitated by densitometry and standardized with the intensity of FLAG-p38 in the precipitates (B). The data shown were reproduced in at least two independent experiments.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 6Activation of p38 MAPK by constitutively active PKG. The ability of PKG kinase activity to cause p38 MAPK activation was examined by overexpressing a truncated version of PKG containing the catalytic region (δPKGc). After 24 h cells were harvested and the phospho-38 levels measured by Western blotting. The effectiveness of the δPKGc to activate p38 MAPK was compared with cells transfected to express ASK1 (as indicated). The expression of the truncated PKG was determined by Western blot analysis of cell extracts using an anti-COOH terminus PKG antibody (lower panel). The result shown is representative of at least two experiments.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Because of its pleiotropic effects, there exists a possibility that NO might activate p38 MAPK by more than one means. To address this issue the effect of overexpression of PKG1α(T516A) on p38 MAPK activation by NO treatment was measured by both Western blotting and by ATF-2-dependent luciferase activity. The 293T cells stimulated with 100 μm SNP-1 for 30 min showed a high phospho-p38 level. Cotransfecting the cells with increasing amounts of the catalytically inactive PKG (T516A) dose-dependently inhibited NO stimulated p38 phosphorylation (Fig.7 A). At 1 μg of DNA/plate the amount of phospho-p38 in the SNP-1-stimulated cells was reduced to basal levels. Similarly, the activation of ATF-2-dependent luciferase activity stimulated by SNP-1 was completely inhibited by expression of the catalytic mutant of PKG1α (Fig. 7 B). Nitric oxide synthesis is induced by stimulation with a variety of different ligands although the function of this in most systems is poorly defined. Synthesis of nitric oxide contributes to vascular-endothelial growth factor stimulation of cell proliferation by activating the ERK pathway (17.Parenti A. Morbidelli L. Cui X.L. Douglas J.G. Hood J.D. Granger H.J. Ledda F. Ziche M. J. Biol. Chem. 1998; 273: 4220-4226Abstract Full Text Full Text PDF PubMed Scopus (396) Google Scholar, 28.Hood J. Granger H.J. J. Biol. Chem. 1998; 273: 23504-23508Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). In a recent study, we demonstrated a role for NO in LPS stimulated p38 MAPK phosphorylation, a process that requires cGMP accumulation (15.Browning D.D. Windes N.D. Ye R.D. J. Biol. Chem. 1999; 274: 537-542Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Results shown here demonstrate that NO can activate p38 MAPK in 293T fibroblasts, suggesting that NO induced p38 MAPK activation is not confined to certain differentiated cell types but is a widespread phenomenon. The induction of ATF-2-dependent gene expression by either NO or 8-Br-cGMP lends further support to the physiological significance of this pathway. As a first step toward understanding the mechanism underlying cGMP-induced activation of p38 MAPK, the current study evaluated the role of cGMP-dependent protein kinase (PKG). Whereas much attention has focused upon PKA as a cyclic nucleotide responsive protein kinase, the function of PKG and how this protein might mediate the effects of NO on cell behavior have not been fully elucidated. Results shown here reveal that blockade of the PKA system does not affect activation of p38 MAPK by cGMP and that the levels of cGMP causing phosphorylation of p38 MAPK do not lead to PKA activation. Together these data indicate that as in other systems, PKG is the likely downstream effector of NO in the pathway leading to activation of p38 MAPK. PKG has three isoforms: PKG1α, PKG1β (products of alternative splicing), and PKG2. These enzymes differ predominantly in the amino-terminal regulatory region and in the intracellular and tissue distribution patterns (2.Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (454) Google Scholar, 34.Lincoln T.M. Komalavilas P. Boerth N.J. MacMillan-Crow L.A. Cornwell T.L. Adv. Pharmacol. 1995; 34: 305-322Crossref PubMed Scopus (87) Google Scholar). Overexpression of wild-type PKG1α potentiated the activation of p38 MAPK by cGMP, and expression of the constitutive catalytic domain of PKG1 conferred increased levels of phosphorylated p38 MAPK in the absence of exogenous cGMP. These data demonstrate that PKG is capable of activating p38 MAPK in these cells. Exogenous expression of catalytically inactive mutants of many kinases has been very useful in establishing specific functions for these proteins as the mutants often behave in a dominant negative fashion. The T516A mutant of PKG has been reported previously to be catalytically inactive in vitro when purified from baculovirus infected SF9 insect cells (33.Feil R. Kellermann J. Hofmann F. Biochemistry. 1995; 34: 13152-13158Crossref PubMed Scopus (29) Google Scholar). Here we show that transfection of this mutant into 293T cells does not confer kinase activity confirming indeed that this mutant has lost kinase activity. Furthermore, our results provide direct evidence for a dominant negative function of this mutant PKG, as it possesses the ability to block cGMP and NO stimulated activation of p38 MAPK. In cells stimulated with exogenous NO, blockade of both p38 phosphorylation and ATF-2 dependent gene expression with the T516A mutant suggests that PKG activation is essential to this pathway and that other mechanisms such as protein nitrosylation are less important. Thus, this mutant PKG will complement the use of the inhibitor KT5823 in studies of PKG where inhibition of its function is required. The mechanism for the dominant negative action of this mutant PKG is currently not known, nor is its effect on other PKG isotypes. Many protein kinases localize to specific regions of the cell by interacting with specific anchoring proteins, and this interaction is essential for enzyme function (35.Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (833) Google Scholar). Because such proteins exist for PKG (36.Vo N.K. Gettemy J.M. Coghlan V.M. Biochem. Biophys. Res. Commun. 1998; 246: 831-835Crossref PubMed Scopus (44) Google Scholar), it is possible that at higher levels of expression the mutant PKG might displace the endogenous enzyme from its anchoring proteins. Further characterization of its mode of action may provide useful information for future application of this dominant negative kinase. It is well established that p38 MAPK can be activated by a large number of environmental factors, and all of them do not activate the same signaling mechanism. Although significant compared with the basal level, the degree of p38 MAPK activation by exogenous NO or cGMP-elevating agents was weaker than that stimulated by TNFα. Similar results were obtained by overexpressing ASK-1 (downstream of TNFα), when compared with p38 MAPK phosphorylation in cells expressing constitutive PKG. The reason for the difference in potency of PKG-mediated versus TNFα induced p38 MAPK phosphorylation was not determined in these experiments. However, this point suggests that the underlying mechanism used by TNFα/ASK-1 to activate the p38 MAPK pathway is likely to be different from that initiated by cGMP/PKG. The finding that NO and 8-Br-cGMP were able to induce ATF-2 reporter activity to the same extent as TNFα demonstrates that the amount of MAPK activity induced by these agents is likely to be physiologically significant and that a certain minimal level of p38 MAPK activation is sufficient for this process. Activation of p38 MAPK leads to its translocation to the nucleus and activation of multiple transcription factors, including ATF-2 and MEF2C (37.Han J. Jiang Y. Li Z. Kravchenko V.V. Ulevitch R.J. Nature. 1997; 386: 296-299Crossref PubMed Scopus (682) Google Scholar). The activation of both p38 MAPK and JNK are central to immediate early gene expression during the inflammatory response (24.Su B. Karin M. Curr. Opin. Immunol. 1996; 8: 402-411Crossref PubMed Scopus (714) Google Scholar, 25.Treisman R. Curr. Opin. Cell Biol. 1996; 8: 205-215Crossref PubMed Scopus (1160) Google Scholar). The activation of p38 MAPK by PKG as demonstrated here indicates a possible role for this enzyme in transcriptional regulation. This notion is supported by the finding that NO synthesis in several systems can cause cGMP-dependent alterations in transcription, including activation of immediate early gene expression (3.Wang X. Robinson P.J. J. Neurochem. 1997; 68: 443-456Crossref PubMed Scopus (271) Google Scholar, 19.Sciorati C. Nistico G. Meldolesi J. Clementi E. Br. J. Pharmacol. 1997; 122: 687-697Crossref PubMed Scopus (45) Google Scholar, 38.Morris B.J. J. Biol. Chem. 1995; 270: 24740-24744Abstract Full Text Full Text PDF PubMed Google Scholar). There are widespread reports that demonstrate transcriptional up-regulation of inducible nitric oxide synthase by cytokines, a process in which p38 MAPK activation is essential (39.Bhat N.R. Zhang P. Lee J.C. Hogan E.L. J. Neurosci. 1998; 18: 1633-1641Crossref PubMed Google Scholar, 40.Bhat N.R. Zhang P. Bhat A.N. J. Neurochem. 1999; 72: 472-478Crossref PubMed Scopus (77) Google Scholar, 41.Chan E.D. Winston B.W. Uh S.T. Wynes M.W. Rose D.M. Riches D.W. J. Immunol. 1999; 162: 415-422PubMed Google Scholar, 42.Larsen C.M. Wadt K.A. Juhl L.F. Andersen H.U. Karlsen A.E. Su M.S. Seedorf K. Shapiro L. Dinarello C.A. Mandrup-Poulsen T. J. Biol. Chem. 1998; 273: 15294-15300Abstract Full Text Full Text PDF PubMed Scopus (160) Google Scholar). The activation of p38 MAPK by PKG as demonstrated here would tend to amplify the cytokine response, perhaps by sustaining MAPK activation in an autoregulatory manner. The cyclic nucleotide-dependent kinases have also been shown directly to mediate some gene expression, although emphasis has been on the ability to activate the transcription factor CREB by direct phosphorylation. These studies have lead to some debate as to how the cytosolically located PKG can activate the predominantly nuclear CREB as a substrate (31.Collins S.P. Uhler M.D. J. Biol. Chem. 1999; 274: 8391-8404Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar, 43.Gudi T. Huvar I. Meinecke M. Lohmann S.M. Boss G.R. Pilz R.B. J. Biol. Chem. 1996; 271: 4597-4600Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, 44.Gudi T. Lohmann S.M. Pilz R.B. Mol. Cell. Biol. 1997; 17: 5244-5254Crossref PubMed Scopus (111) Google Scholar). The activation of MAPKs by PKG can therefore provide an alternative mechanism by which PKG can regulate transcription without nuclear translocation. Although the underlying mechanism used by NO to activate the p38 MAPK pathway are not known, this study demonstrates that cGMP mediated activation of PKG is essential for this process. The biochemical sequence of events leading to activation of ERK can be initiated by diverse extracellular signals, but the pathway converges upon activation of few upstream components (e.g. RAS, Raf). The upstream components leading to activation of p38 MAPK are less defined and in contrast to the role of c-Raf in the ERK pathway, a convergence is not apparent as there are many MEK kinases capable of activating MEK3. The type 1 isoforms of PKG are widely expressed; however, the specific substrates for this enzyme remain poorly defined. Elucidation of the mechanism underlying p38 MAPK activation will require more study, but such efforts might concentrate upon the immediate substrates of this enzyme. We are grateful to Drs. Stanley McKnight, Michael Uhler, Jiahuai Han, and Tatyana. Voyno-Yasenetskaya for their generosity in providing the cDNA constructs used in this study.

Referência(s)